INIS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO
Board Member
Radnostix Inc (INIS)Equibles does not estimate personal net worth.
Get an email with a short summary when Radnostix Inc publishes a filing, an earnings call transcript or a press release.
Get INIS alertsShahe Bagerdjian is recorded as Board Member and CEO at Radnostix Inc (INIS). The newest filing on record that lists Shahe Bagerdjian as Board Member and CEO at Radnostix Inc (INIS) is dated June 4, 2026. Radnostix Inc reported in an 8-K filed July 21, 2026 that Shahe Bagerdjian was appointed director, effective July 16, 2026. Radnostix Inc reported in an 8-K filed May 10, 2023 that Shahe Bagerdjian was appointed President, effective May 8, 2023. The proxy statement of Radnostix Inc reports total compensation of $367,319 for Shahe Bagerdjian in fiscal 2023, including a base salary of $190,978. Radnostix Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Radnostix Inc includes Shahe Bagderjian (CEO and Board Member), Laurie McKenzie-Carter (CFO), W. Matthew Cox (CFO) and 6 others.
“Proposal 1: Election of five directors to serve for a term of one year and until their successors are elected and qualified.”
“On May 8, 2023, International Isotopes Inc. (the “Company”) appointed Shahe Bagerdjian as its President, effective immediately.”
Start not stated–present
Last confirmed June 4, 2026
Start not stated–present
Last confirmed June 4, 2026
Proxy statement
Start not stated–2023-05-24
Last confirmed by a filing; no departure on record
INIS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Radnostix Inc (INIS) | President, Chief Executive Officer | $190,978 | $367,319 |